fda glp-1 compounding enforcement news october 2025 is moving to restrict mass-marketed compounded products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger to protect patients from unverified February 17, 2026: Pennsylvania compounding

The REDEFINE 1 and REDEFINE 2 Phase 3 trials used a once-weekly subcutaneous dose of cagrilintide 2.4 mg combined with semaglutide 2.4 mg, reached after roughly 16 weeks of dose titration

2003 , 6 , 4166 [3] Pooyandjoo, M

So, while you may be interested in taking a so-called natural GLP-1 supplement, youre unlikely to see a major impact on your weight at least, not nearly at the level that youd see if you took a GLP-1 receptor agonist medication

How Semaglutide Works in Your Body To understand why the 48-hour rule exists, it helps to look at how the medication is processed

Zinc: Fact Sheet for Health Professionals

In line with these studies, forebrain-specific MET cKO mice show altered circuit formation and function including synaptic plasticity